Comments
Loading...
Harvard Bioscience Earnings Estimates, EPS & Revenue | NASDAQ:HBIO | Benzinga
Harvard Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$19.20M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$94.14M
Analyze the earnings history of Harvard Bioscience using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HBIO | Harvard Bioscience | $0.02 | -$0.04 | — | — | $24.51M | $19.20M | — | — | 05/09/2025 | Get Alert |
| HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.06 | 20.00% | $28.15M | $24.15M | $24.56M | 1.68% | 03/12/2025 | Get Alert |
| HBIO | Harvard Bioscience | $0.01 | $0.03 | -$0.02 | -166.67% | $25.36M | $25.30M | $21.97M | -13.16% | 11/07/2024 | Get Alert |
| HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.00 | -100.00% | $28.76M | $26.40M | $23.10M | -12.51% | 08/08/2024 | Get Alert |
| HBIO | Harvard Bioscience | $0.06 | $0.02 | $0.02 | 0.00% | $29.98M | $25.79M | $24.51M | -4.96% | 05/07/2024 | Get Alert |
| HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.04 | -20.00% | $28.43M | $29.11M | $28.15M | -3.29% | 03/07/2024 | Get Alert |
| HBIO | Harvard Bioscience | -$0.01 | $0.04 | $0.01 | -75.00% | $26.92M | $28.02M | $25.36M | -9.48% | 11/07/2023 | Get Alert |
| HBIO | Harvard Bioscience | $0.05 | $0.05 | $0.04 | -20.00% | $29.21M | $29.50M | $28.76M | -2.51% | 08/08/2023 | Get Alert |
| HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.06 | 20.00% | $28.78M | $28.85M | $29.98M | 3.90% | 04/25/2023 | Get Alert |
| HBIO | Harvard Bioscience | $0.08 | $0.03 | $0.04 | 33.33% | $33.05M | $30.33M | $28.43M | -6.27% | 03/09/2023 | Get Alert |
| HBIO | Harvard Bioscience | $0.06 | $0.07 | -$0.01 | -114.29% | $29.66M | $28.89M | $26.92M | -6.81% | 11/08/2022 | Get Alert |
| HBIO | Harvard Bioscience | $0.06 | $0.06 | $0.05 | -16.67% | $29.20M | $30.49M | $29.21M | -4.20% | 08/03/2022 | Get Alert |
| HBIO | Harvard Bioscience | $0.05 | $0.05 | $0.04 | -20.00% | $26.99M | $28.77M | $28.78M | 0.03% | 05/04/2022 | Get Alert |
| HBIO | Harvard Bioscience | $0.08 | $0.10 | $0.08 | -20.00% | $30.98M | $32.96M | $33.05M | 0.29% | 03/08/2022 | Get Alert |
| HBIO | Harvard Bioscience | $0.04 | $0.06 | $0.06 | 0.00% | $24.04M | $27.91M | $29.66M | 6.28% | 11/03/2021 | Get Alert |
| HBIO | Harvard Bioscience | $0.05 | $0.06 | $0.06 | 0.00% | $23.31M | $27.67M | $29.20M | 5.52% | 08/05/2021 | Get Alert |
| HBIO | Harvard Bioscience | -$0.01 | $0.03 | $0.05 | 66.67% | $23.77M | $25.73M | $26.99M | 4.89% | 05/06/2021 | Get Alert |
| HBIO | Harvard Bioscience | $0.08 | $0.06 | $0.08 | 33.33% | $30.97M | $27.13M | $30.98M | 14.21% | 03/10/2021 | Get Alert |
| HBIO | Harvard Bioscience | $0.04 | $0.03 | $0.04 | 33.33% | $27.42M | $24.05M | $24.04M | -0.05% | 11/05/2020 | Get Alert |
| HBIO | Harvard Bioscience | $0.04 | -$0.03 | $0.05 | 266.67% | $29.58M | $22.19M | $23.31M | 5.04% | 08/05/2020 | Get Alert |
| HBIO | Harvard Bioscience | $0.02 | $0.03 | -$0.01 | -133.33% | $28.20M | $27.87M | $23.77M | -14.71% | 05/05/2020 | Get Alert |
Harvard Bioscience (HBIO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-12 | $0.06 | $0.05 | 20.0 % |
| Q3 | 2024-11-07 | $-0.02 | $0.03 | -166.7 % |
| Q2 | 2024-08-08 | $0 | $0.05 | -100.0 % |
| Q1 | 2024-05-07 | $0.02 | $0.02 | 0.00 % |
Harvard Bioscience (HBIO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-12 | $24.56M | $24.15M | 1.68 % |
| Q3 | 2024-11-07 | $21.97M | $25.30M | -13.2 % |
| Q2 | 2024-08-08 | $23.10M | $26.40M | -12.5 % |
| Q1 | 2024-05-07 | $24.51M | $25.79M | -4.96 % |
FAQ
When is Harvard Bioscience (NASDAQ:HBIO) reporting earnings?
Harvard Bioscience (HBIO) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on March 12, 2025 for Q4.
What were the latest earnings per share (EPS) for Harvard Bioscience (NASDAQ:HBIO)?
The Actual EPS was $0.06, which beat the estimate of $0.05.
What were Harvard Bioscience’s (NASDAQ:HBIO) revenues?
The Actual Revenue was $24.6M, which beat the estimate of $24.1M.
Browse earnings estimates, EPS, and revenue on all stocks.
